Ignite Creation Date:
2024-07-17 @ 11:42 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06466369
Status:
COMPLETED
Last Update Posted:
2024-06-20
First Post:
2024-06-14
Brief Title:
Administration of Tadalafil in Patients With Benign Prostatic Hyperplasia
Sponsor:
Al-Azhar University
Organization:
Al-Azhar University
Study Overview
Official Title:
Efficacy and Safety of Once Daily Administration Tadalafil in Patients With Benign Prostatic Hyperplasia
Status:
COMPLETED
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of the present study is to evaluate the efficacy and safety of once daily administration PDE5 inhibitors tadalafil for 3 months as anti-inflammatory antiproliferative and relaxant effects in ED with BPH patients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None